CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 78 filers reported holding CUE BIOPHARMA INC in Q1 2024. The put-call ratio across all filers is 3.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $219,546 | -84.7% | 177,053 | -76.7% | 0.00% | – |
| Q1 2024 | $1,436,013 | -20.4% | 759,795 | +11.1% | 0.00% | – |
| Q4 2023 | $1,804,955 | +12.4% | 683,695 | -2.1% | 0.00% | – |
| Q3 2023 | $1,605,849 | -32.4% | 698,195 | +7.2% | 0.00% | – |
| Q2 2023 | $2,377,227 | +371.8% | 651,295 | +361.4% | 0.00% | – |
| Q1 2023 | $503,916 | -37.4% | 141,153 | -50.0% | 0.00% | – |
| Q4 2022 | $804,572 | +155.4% | 282,306 | +100.0% | 0.00% | – |
| Q3 2022 | $315,000 | -20.3% | 141,153 | -11.0% | 0.00% | – |
| Q2 2022 | $395,000 | -88.9% | 158,604 | -78.2% | 0.00% | – |
| Q1 2022 | $3,548,000 | -81.1% | 727,023 | -56.3% | 0.00% | -100.0% |
| Q4 2021 | $18,800,000 | -1.2% | 1,662,252 | +27.2% | 0.00% | 0.0% |
| Q3 2021 | $19,035,000 | +11.1% | 1,306,446 | -11.1% | 0.00% | 0.0% |
| Q2 2021 | $17,126,000 | +2.4% | 1,470,075 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $16,721,000 | -4.0% | 1,370,605 | -1.5% | 0.00% | 0.0% |
| Q4 2020 | $17,409,000 | -14.5% | 1,391,578 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $20,367,000 | -19.1% | 1,353,265 | +31.8% | 0.00% | -50.0% |
| Q2 2020 | $25,169,000 | +377.0% | 1,026,881 | +176.2% | 0.00% | – |
| Q1 2020 | $5,276,000 | -0.4% | 371,783 | +11.4% | 0.00% | – |
| Q4 2019 | $5,298,000 | +119.8% | 333,701 | +16.7% | 0.00% | – |
| Q3 2019 | $2,410,000 | -7.1% | 285,929 | -0.9% | 0.00% | – |
| Q2 2019 | $2,593,000 | +27.7% | 288,386 | +9.8% | 0.00% | – |
| Q1 2019 | $2,030,000 | +57.5% | 262,578 | -4.3% | 0.00% | – |
| Q4 2018 | $1,289,000 | -47.0% | 274,358 | +2.0% | 0.00% | – |
| Q3 2018 | $2,432,000 | -5.7% | 268,981 | +23.7% | 0.00% | – |
| Q2 2018 | $2,579,000 | +55.5% | 217,454 | +84.3% | 0.00% | – |
| Q1 2018 | $1,658,000 | – | 118,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 890,000 | $7,503,000 | 0.50% |
| Nantahala Capital Management | 1,378,198 | $11,618,000 | 0.43% |
| 683 Capital Management, LLC | 300,000 | $2,529,000 | 0.28% |
| Rock Creek Group, LP | 42,505 | $358,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $422,000 | 0.06% |
| Parian Global Management LP | 11,000 | $93,000 | 0.04% |
| Sigma Planning Corp | 60,210 | $508,000 | 0.02% |
| D'Orazio & Associates, Inc. | 2,000 | $17,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 26,602 | $224,000 | 0.01% |
| STIFEL FINANCIAL CORP | 55,855 | $471,000 | 0.00% |